Daniel E Gustavson1,2, Amy J Jak3,4, Jeremy A Elman3,5, Matthew S Panizzon3,5, Carol E Franz3,5, Katherine A Gifford2, Chandra A Reynolds6, Rosemary Toomey7, Michael J Lyons7, William S Kremen3,5,8. 1. Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. 4. Psychology Service, Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA. 5. Center for Behavior Genetics of Aging, University of California, San Diego, La Jolla, CA, USA. 6. Department of Psychology, University of California, Riverside, Riverside, CA, USA. 7. Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA. 8. Center of Excellence for Stress and Mental Health, Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA.
Abstract
BACKGROUND: Although not strongly correlated with current objective cognitive ability, subjective cognitive decline (SCD) is a risk factor for Alzheimer's disease. Most studies focus on SCD in relation to future decline rather than objective prior decline that it purportedly measures. OBJECTIVE: We evaluated whether self-report of cognitive decline-as a continuous measure-corresponds to objectively-assessed episodic memory and executive function decline across the same period. METHODS: 1,170 men completed the Everyday Cognition Questionnaire (ECog) at mean age 68 assessing subjective changes in cognitive ability relative to 10 years prior. A subset had mild cognitive impairment (MCI), but MCI was diagnosed without regard to subjective decline. Participants completed up to 3 objective assessments of memory and executive function (M = 56, 62, and 68 years). Informant-reported ECogs were completed for 1,045 individuals. Analyses controlled for depression and anxiety symptoms assessed at mean age 68. RESULTS: Participant-reported ECog scores were modestly associated with objective decline for memory (β= -0.23, 95%CI [-0.37, -0.10]) and executive function (β= -0.19, 95%CI [-0.33, -0.05]) over the same time period. However, these associations were nonsignificant after excluding MCI cases. Results were similar for informant ratings. Participant-rated ECog scores were more strongly associated with concurrent depression and anxiety symptoms, (β= 0.44, 95%CI [0.36, 0.53]). CONCLUSION: Continuous SCD scores are correlated with prior objective cognitive changes in non-demented individuals, though this association appears driven by individuals with current MCI. However, participants' current depression and anxiety ratings tend to be strongly associated with their SCD ratings. Thus, what primarily drives SCD ratings remains unclear.
BACKGROUND: Although not strongly correlated with current objective cognitive ability, subjective cognitive decline (SCD) is a risk factor for Alzheimer's disease. Most studies focus on SCD in relation to future decline rather than objective prior decline that it purportedly measures. OBJECTIVE: We evaluated whether self-report of cognitive decline-as a continuous measure-corresponds to objectively-assessed episodic memory and executive function decline across the same period. METHODS: 1,170 men completed the Everyday Cognition Questionnaire (ECog) at mean age 68 assessing subjective changes in cognitive ability relative to 10 years prior. A subset had mild cognitive impairment (MCI), but MCI was diagnosed without regard to subjective decline. Participants completed up to 3 objective assessments of memory and executive function (M = 56, 62, and 68 years). Informant-reported ECogs were completed for 1,045 individuals. Analyses controlled for depression and anxiety symptoms assessed at mean age 68. RESULTS: Participant-reported ECog scores were modestly associated with objective decline for memory (β= -0.23, 95%CI [-0.37, -0.10]) and executive function (β= -0.19, 95%CI [-0.33, -0.05]) over the same time period. However, these associations were nonsignificant after excluding MCI cases. Results were similar for informant ratings. Participant-rated ECog scores were more strongly associated with concurrent depression and anxiety symptoms, (β= 0.44, 95%CI [0.36, 0.53]). CONCLUSION: Continuous SCD scores are correlated with prior objective cognitive changes in non-demented individuals, though this association appears driven by individuals with current MCI. However, participants' current depression and anxiety ratings tend to be strongly associated with their SCD ratings. Thus, what primarily drives SCD ratings remains unclear.
Authors: Matthew S Panizzon; Michael C Neale; Anna R Docherty; Carol E Franz; Kristen C Jacobson; Rosemary Toomey; Hong Xian; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Michael J Lyons; William S Kremen Journal: Psychol Aging Date: 2015-05-04
Authors: Daniel E Gustavson; Matthew S Panizzon; Jeremy A Elman; Carol E Franz; Chandra A Reynolds; Kristen C Jacobson; Naomi P Friedman; Hong Xian; Rosemary Toomey; Michael J Lyons; William S Kremen Journal: Psychol Aging Date: 2018-03
Authors: William S Kremen; Matthew S Panizzon; Carol E Franz; Kelly M Spoon; Eero Vuoksimaa; Kristen C Jacobson; Terrie Vasilopoulos; Hong Xian; Jeanne M McCaffery; Brinda K Rana; Rosemary Toomey; Ruth McKenzie; Michael J Lyons Journal: Psychol Aging Date: 2014-06
Authors: Zvinka Z Zlatar; Raeanne C Moore; Barton W Palmer; Wesley K Thompson; Dilip V Jeste Journal: J Geriatr Psychiatry Neurol Date: 2014-03-10 Impact factor: 2.680
Authors: Daniel E Gustavson; Matthew S Panizzon; Carol E Franz; Naomi P Friedman; Chandra A Reynolds; Kristen C Jacobson; Hong Xian; Michael J Lyons; William S Kremen Journal: Neuropsychology Date: 2017-08-31 Impact factor: 3.295
Authors: José L Molinuevo; Laura A Rabin; Rebecca Amariglio; Rachel Buckley; Bruno Dubois; Kathryn A Ellis; Michael Ewers; Harald Hampel; Stefan Klöppel; Lorena Rami; Barry Reisberg; Andrew J Saykin; Sietske Sikkes; Colette M Smart; Beth E Snitz; Reisa Sperling; Wiesje M van der Flier; Michael Wagner; Frank Jessen Journal: Alzheimers Dement Date: 2016-11-05 Impact factor: 21.566
Authors: Amy J Jak; Mark W Bondi; Lisa Delano-Wood; Christina Wierenga; Jody Corey-Bloom; David P Salmon; Dean C Delis Journal: Am J Geriatr Psychiatry Date: 2009-05 Impact factor: 4.105
Authors: Riki E Slayday; Daniel E Gustavson; Jeremy A Elman; Asad Beck; Linda K McEvoy; Xin M Tu; Bin Fang; Richard L Hauger; Michael J Lyons; Ruth E McKenzie; Mark E Sanderson-Cimino; Hong Xian; William S Kremen; Carol E Franz Journal: J Int Neuropsychol Soc Date: 2020-07-14 Impact factor: 2.892